Back to trial details

Intake questionnaire

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Applying to Dana Farber Cancer Institute · Boston, Massachusetts

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Non-Small Cell Lung Cancer, NSCLC?
3. Are you able to travel to Boston for study visits?